IL2 is used for advanced metastatic renal cell cancer and melanoma [16]; IFNα is indicated for hairy cell leukemia, follicular non-Hodgkins’s lymphoma, melanoma, and AIDS-related Kaposi’s sarcoma. This evidence concerns the gene IL2 and melanoma.